Rankings
▼
Calendar
ORGO FY 2016 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
FY 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$208,698
Operating Income
$208,698
Net Income
-$208,698
EPS (Diluted)
$-0.02
Cash Flow
Operating Cash Flow
-$562,233
Free Cash Flow
-$2M
Stock-Based Comp.
$473,000
Balance Sheet
Total Assets
$311M
Total Liabilities
$11M
Stockholders' Equity
$300M
Cash & Equivalents
$1M
← Q1 2016
All Quarters
